Soluble CD14 Subtype—A New Biomarker in Predicting the Outcome of Critically Ill Septic Patients

Giovanni Matera(Magna Graecia University), Alfredo Focà, Maria Teresa Loria(Magna Graecia University), B Amantea(Magna Graecia University), Nadia Marascio(Universitat Autònoma de Barcelona), Pio Settembre(Magna Graecia University), Cinzia Peronace(Magna Graecia University), Maria Carla Liberto, Giorgio Settimo Barreca, Vito Marano(Magna Graecia University), Angela Quirino(Magna Graecia University), Luisa Galati(European Institute of Oncology)
The American Journal of the Medical Sciences
April 7, 2017
10.1016/j.amjms.2017.03.036
Cited by 26

Related Papers

HPV and head and neck cancers: Towards early diagnosis and prevention
|Tumour Virus Research|2022|78
New findings in HCV genotype distribution in selected West European, Russian and Israeli regions
|Journal of Clinical Virology|2016|73
Human Oncogenic Viruses: Characteristics and Prevention Strategies—Lessons Learned from Human Papillomaviruses
|Viruses|2024|41
Anti-Cancer Vaccine for HPV-Associated Neoplasms: Focus on a Therapeutic HPV Vaccine Based on a Novel Tumor Antigen Delivery Method Using Endogenously Engineered Exosomes
|Cancers|2019|37
Analyzing breast cancer invasive disease event classification through explainable artificial intelligence
|Frontiers in Medicine|2023|31